Nicole Schmitt
- Department of Otolaryngology Head and Neck Surgery
Associate Professor
Overview
Dr. Nicole Schmitt's clinical and research work is focused on head and neck surgical oncology and novel therapeutic combinations. She received her MD degree at Washington University School of Medicine in 2006. She completed her general surgery internship as well as her research fellowship and residency in otolaryngology head and neck surgery at the University of Washington, and completed a fellowship in head and neck surgery and tumor biology at the University of Pittsburgh.
Prior to joining the Emory Otolaryngology faculty in 2020, Dr. Schmitt was a faculty member at Johns Hopkins University, and a special volunteer and principal investigator for the Integrative Therapeutics Program of the Otolaryngology Surgeon Scientist Program, National Institute on Deafness and Other Communication Disorders, National Institutes of Health.
Academic Appointment
- Associate Professor, Department of Otolaryngology Head and Neck Surgery, Emory University School of Medicine
- Co-Director, Translational Research, Head & Neck Program, Winship Cancer Institute
Education
Degrees
- MD from Washington University School of Medicine, St. Louis
Research
Publications
-
Radiotherapy With Cisplatin vs Carboplatin Paclitaxel for Head and Neck Squamous Cell Carcinoma.
JAMA Otolaryngol Head Neck Surg
06/26/2025 Authors: Abousaud M; Pamulapati S; Rashid S; Lozano F; Shepherd M; Fowowe B; Cao Y; Kim P; Liu Y; Bates JE -
Treatment of recurrent oral carcinoma cuniculatum with immune checkpoint blockade: A case report and literature review.
Oral Oncol Rep Volume: 14
06/01/2025 Authors: Jones W; Kaka AS; Rudra S; Lubin D; Saeed F; Magliocca KR; Saba NF; Schmitt NC -
Reirradiation: Standards, challenges, and patient-focused strategies across tumor types.
CA Cancer J Clin
05/29/2025 Authors: Beddok A; Willmann J; Embring A; Appelt AL; Balermpas P; Chua K; Choi JI; Elger BS; Gabrys D; Hoskin P -
Early-phase trial of IAP antagonist tolinapant and definitive radiation in cisplatin-ineligible patients with advanced head and neck cancer.
Clin Cancer Res
05/12/2025 Authors: Schmitt NC; Stokes WA; Bates JE; Kinney BLC; Remick J; McDonald MW; Rudra S; Steininger M; Oyewole M; Patel MR -
Combination radiation and PD-L1 enhance tumor control by stimulating CD8+PD-1+TCF-1+T cells in the tumor-draining lymph node.
Nat Commun Volume: 16 Page(s): 3522
04/14/2025 Authors: Shen Y; Connolly E; Aiello M; Zhou C; Chappa P; Song H; Tippitak P; Clark T; Cardenas M; Prokhnevska N -
Statin Drugs Are Associated With Response to Immune Checkpoint Blockade in Recurrent/Metastatic Head and Neck Cancer.
Cancer Med Volume: 14 Page(s): e70718
03/01/2025 Authors: Kristoff TJ; Evans S; Nayi P; Abousaud M; Goyal S; Liu Y; Shin D; Steuer CE; Saba NF; Schmitt NC -
Radiologic findings of occult nodal metastasis during clinically-N0 salvage total laryngectomy.
Head Neck Volume: 47 Page(s): 201 - 214
01/01/2025 Authors: Chan TG; Wicks J; Sethi I; Becker J; Brandon D; Schmitt NC; Kaka A; Boyce B; Baddour HM; El-Deiry MW -
Age and postoperative swallowing function in patients treated for advanced oral cancer: A retrospective study.
J Geriatr Oncol Volume: 15 Page(s): 101841
11/01/2024 Authors: Amos SE; Daoud GE; Patel SR; Burnham AJ; Ottenstein L; Baddour HM; Tkaczuk A; Schmitt NC -
Pembrolizumab and Cabozantinib in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Long-term Survival Update with a Biomarker Analysis.
Clin Cancer Res Volume: 30 Page(s): 4601 - 4608
10/15/2024 Authors: Saba NF; Chaudhary R; Kirtane K; Marra A; Ekpenyong A; McCook-Veal A; Schmitt NC; Gross JH; Patel MR; Remick J -
Assessing survival outcomes of patients with oral tongue squamous cell carcinoma: Focus on age, sex, and stage.
Head Neck Volume: 46 Page(s): 2167 - 2177
09/01/2024 Authors: Pamulapati S; Abousaud M; Li Y; Ekpenyong A; Rudra S; Remick JS; Bates JE; Stokes WA; McDonald MW; Schmitt NC